Medication info
Pimace Tablet 60/2.5 mg (Pimasartan Potassium, Esamlodipine)

Pimace Tablet 60/2.5 mg (Pimasartan Potassium, Esamlodipine)

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate›66.01mg / 1 tabletS-Amlodipine Besylate 2.5 Hydrate›3.74mg / 1 tablet
Manufacturer / importer
Dongkook Pharmaceutical Co., Ltd.
Appearance
Yellow, rounded square film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202300116 · Approved 2023.01.06 · Insurance code 653405400

Summary

Main use
Treatment of essential hypertension not adequately controlled with fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using fimasartan. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams as monotherapy. ㆍ 60/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy. ㆍ 60/5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy or this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dose adjustment is required for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). However, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 milligrams in this medicine. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. This medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy of this medicine in pediatric and adolescent patients aged 18 years or younger have not been established.

Ingredients

Manufacturer
Dongkook Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with fimasartan monotherapy

  • Essential hypertension
View approved original text

Used in the treatment of essential hypertension when blood pressure is not adequately controlled with Pimasartan Potassium monotherapy.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using fimasartan. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams as monotherapy. ㆍ 60/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy. ㆍ 60/5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy or this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dose adjustment is required for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). However, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 milligrams in this medicine. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. This medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy of this medicine in pediatric and adolescent patients aged 18 years or younger have not been established.

Precautions

This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Do not use if you have an allergy to the active ingredient or similar medications, if you are pregnant or breastfeeding, if you are undergoing renal dialysis, if you have moderate to severe hepatic impairment, if you have biliary obstruction, if you are a diabetic patient taking certain antihypertensive drugs, if you have lactose intolerance, if you have severe aortic stenosis, or in shock. Patients with low blood volume or sodium, renal function impairment, renovascular hypertension, aortic or mitral stenosis, primary aldosteronism, severe hypotension, elderly patients, and those with allergies to certain dyes should use this medication with special caution. Side effects such as dizziness, headache, facial edema, urinary disturbance, insomnia, and flushing may occur. Rarely, serious adverse reactions have been reported; consult medical personnel immediately if any unusual symptoms arise. Hypotension, electrolyte imbalance, and hyperkalemia may occur; blood pressure and serum potassium levels should be monitored regularly. Special caution is needed for patients with impaired renal function. This medication may interact with other antihypertensive drugs, certain diuretics, potassium supplements, lithium, and non-steroidal anti-inflammatory drugs; inform your healthcare provider of any other medications you are taking. It is advisable that pregnant or breastfeeding women avoid this medication, and consult a doctor if necessary. Safety for use in children under 18 years has not been established, so it is preferable not to use it. No dosage adjustment is necessary for elderly patients; however, they should use it with caution due to potential sensitivity. Do not administer to patients with severe hepatic impairment. In case of overdose, symptoms such as severe hypotension, palpitations, and bradycardia may occur, requiring immediate medical attention. Store this medication out of reach of children and avoid transferring it to other containers.

Side effects

Dizziness, orthostatic dizziness, headache, facial swelling, peripheral edema, urination disorders, insomnia, flushing, fainting, sedation, migraine, dyspepsia, vomiting, nausea, upper abdominal pain, weakness, foreign body sensation, elevated liver enzymes, decreased platelet count, increased serum creatine phosphokinase, cough, muscle contractions, musculoskeletal stiffness, itching, localized urticaria, facial flushing, erectile dysfunction, epilepsy, amyotrophic lateral sclerosis, neuropathy, neuronitis, facial paralysis, normal pressure hydrocephalus, spinal canal stenosis, acute pancreatitis, intestinal obstruction, hemorrhagic duodenal ulcers, appendicitis, hemorrhoids, abdominal pain, intracranial hemorrhage, transient ischemic attack, atherosclerosis, worsening cerebral infarction, cerebral hemorrhage, liver cancer, colorectal carcinoma, neoplasm of unspecified type, cervical cancer, prostate cancer, acute renal failure, chronic renal failure, kidney stones, pyelonephritis, urinary incontinence, rhinitis, pneumonitis, pharyngitis, pneumonia, lung disease, death, worsening back pain, osteoarthritis, arthritis, hypoglycemia, hyperkalemia, pulmonary embolism, purpura, bradycardia, atrial fibrillation, coronary artery disease, aortic stenosis, heart failure, hypertension, acute hepatitis, benign pituitary neoplasm, otitis media, uterine prolapse, recurrent cancer, fracture, chest pain, fatigue, lethargy, pain, weight gain, weight loss, hypotension, vasculitis, hypertension, sensory loss, paresthesia, peripheral neuropathy, taste changes, tremors, extrapyramidal disorder, gynecomastia, changes in bowel habits, dry mouth, gingival hypertrophy, pancreatitis, hyperglycemia, arthralgia, low back pain, muscle cramps, myalgia, leukopenia, thrombocytopenia, mood changes, dyspnea, hair loss, hyperhidrosis, purpura, skin pigmentation changes, urticaria, toxic epidermal necrolysis, ear ringing, visual disturbances, increased urination frequency, nocturia, hepatitis, jaundice, pruritus, rash, angioedema, polymorphic erythema, myocardial infarction, arrhythmia, chest pain, hypotension, sinoatrial block, atrioventricular block, abdominal discomfort, retrosternal pain, diarrhea, loose stools, constipation, skin flushing, maculopapular rash, heaviness, warmth, glucose intolerance, weakness, elevated serum potassium, increased serum creatinine, increased blood urea, hypotension, loss of consciousness, dyspnea, hypotension, blood pressure fluctuations, hypertension, purpura, fatty liver, gastrointestinal edema after using angiotensin II receptor antagonists, abdominal pain, nausea, vomiting, diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light; it should be stored in a special container that does not allow light in. Additionally, it is important to store it at room temperature, between 1 and 30 degrees Celsius, to maintain its effectiveness.

Appearance and packaging

Appearance

Yellow, rounded square film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.